4.3 Article

p53 Isoforms: Key Regulators of the Cell Fate Decision

期刊

出版社

COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/cshperspect.a026039

关键词

-

资金

  1. Breast Cancer Now [2012MaySF127]

向作者/读者索取更多资源

It is poorly understood how a single protein, p53, can be responsive to so many stress signals and orchestrates very diverse cell responses to maintain/restore cell/tissue functions. The uncovering that TP53 gene physiologically expresses, in a tissue-dependent manner, several p53 splice variants (isoforms) provides an explanation to its pleiotropic biological activities. Here, we summarize a decade of research on p53 isoforms. The clinical studies and the diverse cellular and animal models of p53 isoforms (zebrafish, Drosophila, and mouse) lead us to realize that a p53-mediated cell response is, in fact, the sum of the intrinsic activities of the coexpressed p53 isoforms and that unbalancing expression of different p53 isoforms leads to cancer, premature aging, (neuro) degenerative diseases, inflammation, embryo malformations, or defects in tissue regeneration. Cracking the p53 isoforms' code is, thus, a necessary step to improve cancer treatment. It also opens new exciting perspectives in tissue regeneration.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Porcine model elucidates function of p53 isoform in carcinogenesis and reveals novel circTP53 RNA

Guanglin Niu, Isabel Hellmuth, Tatiana Flisikowska, Hubert Pausch, Beate Rieblinger, Alexander Carrapeiro, Benjamin Schade, Brigitte Boehm, Eva Kappe, Konrad Fischer, Bernhard Klinger, Katja Steiger, Reiner Burgkart, Jean-Christophe Bourdon, Dieter Saur, Alexander Kind, Angelika Schnieke, Krzysztof Flisikowski

Summary: The mutation in TP53 gene in pig models leads to the development of tumors like osteosarcoma, pointing out similarities with human TP53. Specific TP53 isoforms determine the tumor spectrum in pigs, with circTP53 playing a critical role in malignant transformation.

ONCOGENE (2021)

Article Biochemistry & Molecular Biology

Inhibition of nonsense-mediated decay rescues p53β/γ isoform expression and activates the p53 pathway in and select-mutant cancers

Jayanthi P. Gudikote, Tina Cascone, Alissa Poteete, Piyada Sitthideatphaiboon, Qiuyu Wu, Naoto Morikawa, Fahao Zhang, Shaohua Peng, Pan Tong, Lerong Li, Li Shen, Monique Nilsson, Phillip Jones, Erik P. Sulman, Jing Wang, Jean-Christophe Bourdon, Faye M. Johnson, John Heymach

Summary: p53 inactivation is present in almost all tumors, making p53 reactivation strategies an important aspect of cancer therapy. Inhibition of nonsense-mediated decay (NMD) can upregulate p53 beta and p53 gamma levels, restore p53 pathway activation, and induce tumor suppressive activities. NMD inhibition is identified as a novel therapeutic strategy for restoration of p53 function in p53-deficient tumors.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Multidisciplinary Sciences

Δ133p53β isoform pro-invasive activity is regulated through an aggregation-dependent mechanism in cancer cells

Nikola Arsic, Tania Slatter, Gilles Gadea, Etienne Villain, Aurelie Fournet, Marina Kazantseva, Frederic Allemand, Nathalie Sibille, Martial Seveno, Sylvain de Rossi, Sunali Mehta, Serge Urbach, Jean-Christophe Bourdon, Pau Bernado, Andrey Kajava, Antony Braithwaite, Pierre Roux

Summary: The p53 isoform Delta 133p53 beta promotes intrinsic oncogenic functions, with its activity regulated through an aggregation-dependent mechanism. Interaction with partners like p63 family members or the CCT chaperone complex influences cancer cell features such as migration and invasion by modulating Delta 133p53 beta activity.

NATURE COMMUNICATIONS (2021)

Article Oncology

Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity

Kevin Jan Legscha, Edite Antunes Ferreira, Antonios Chamoun, Alexander Lang, Mohamed Hemaid Sayed Awwad, Gigi Nu Hoang Quy Ton, Danuta Galetzka, Borhane Guezguez, Michael Hundemer, Jean-Christophe Bourdon, Markus Munder, Matthias Theobald, Hakim Echchannaoui

Summary: This study revealed a broad effect of the Delta 133p53 alpha isoform in regulating T lymphocyte function. Enhancing the fitness and effector functions of senescent T cells by modulating p53 isoforms could be utilized for future translational research to improve cancer immunotherapy and immunosenescence-related diseases.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Hematology

Expression of p53 protein isoforms predicts survival in patients with multiple myeloma

Elizabeta A. Rojas, Luis A. Corchete, Cristina De Ramon, Patryk Krzeminski, Dalia Quwaider, Ramon Garcia-Sanz, Joaquin Martinez-Lopez, Albert Oriol, Laura Rosinol, Joan Blade, Juan Jose Lahuerta, Jesus F. San Miguel, Marcos Gonzalez, Maria Victoria Mateos, Jean-Christophe Bourdon, Irena Misiewicz-Krzeminska, Norma C. Gutierrez

Summary: This study demonstrates for the first time the prognostic value of p53 isoforms in multiple myeloma patients, providing new insights into the role of p53 protein dysregulation in multiple myeloma biology.

AMERICAN JOURNAL OF HEMATOLOGY (2022)

Review Biochemistry & Molecular Biology

Adaptive homeostasis and the p53 isoform network

Sunali Mehta, Hamish Campbell, Catherine J. Drummond, Kunyu Li, Kaisha Murray, Tania Slatter, Jean-Christophe Bourdon, Antony W. Braithwaite

Summary: p53 is a crucial protein in maintaining biological homeostasis, with its network playing a vital role in maintaining stability within multicellular organisms, facilitating cooperation between cells to adapt to environmental changes.

EMBO REPORTS (2021)

Article Oncology

Effect of p53 and its N-terminally truncated isoform, Δ40p53, on breast cancer migration and invasion

Xiajie Zhang, Kira Groen, Brianna C. Morten, Luiza Steffens Reinhardt, Hamish G. Campbell, Antony W. Braithwaite, Jean-Christophe Bourdon, Kelly A. Avery-Kiejda

Summary: This study aimed to evaluate the role of Delta 40p53 in breast cancer migration and invasion, finding an association between Delta 40p53 and gene expression profiles. Knockdown of both p53 alpha and Delta 40p53 resulted in increased proliferation, while overexpression of Delta 40p53 reduced proliferation rates and decreased migratory and invasive properties of the cells. These results suggest that at a basal level, Delta 40p53 works similarly to p53 alpha in suppressing cellular mobility and proliferation.

MOLECULAR ONCOLOGY (2022)

Article Cell Biology

p53 isoforms differentially impact on the POLι dependent DNA damage tolerance pathway

Yitian Guo, Melanie Rall-Scharpf, Jean-Christophe Bourdon, Lisa Wiesmuller, Stephanie Biber

Summary: This study demonstrates that different p53 isoforms have varying effects on the p53-POL iota-dependent DNA damage tolerance (DDT) pathway. Despite lacking the biochemical activities required for this pathway, all alternative isoforms exhibit impairments in promoting POL iota recruitment to PCNA and decelerating DNA replication.

CELL DEATH & DISEASE (2021)

Article Oncology

Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer

Flora Nguyen Van Long, Audrey Lardy-Cleaud, Dimitri Carene, Caroline Rossoni, Frederic Catez, Paul Rollet, Nathalie Pion, Deborah Monchiet, Agathe Dolbeau, Marjorie Martin, Valentin Simioni, Susan Bray, Doris Le Beherec, Fernanda Mosele, Ibrahim Bouakka, Amelie Colombe-Vermorel, Laetitia Odeyer, Alexandra Diot, Lee B. Jordan, Alastair M. Thompson, Francoise Jamen, Thierry Dubois, Sylvie Chabaud, Stefan Michiels, Isabelle Treilleux, Jean-Christophe Bourdon, David Perol, Alain Puisieux, Fabrice Andre, Jean-Jacques Diaz, Virginie Marcel

Summary: FBL has been identified as a powerful independent marker of breast cancer prognosis related to ribosome biogenesis. Surprisingly, low activation of ribosome biogenesis is also associated with poor outcome.

BMC CANCER (2022)

Article Biochemistry & Molecular Biology

Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer

Luiza Steffens Reinhardt, Kira Groen, Brianna C. Morten, Jean-Christophe Bourdon, Kelly A. Avery-Kiejda

Summary: TP53 mutations are associated with tumor progression, therapy resistance, and poor prognosis in breast cancer. However, other mechanisms, such as p53 isoform dysregulation, may contribute to the disruption of the p53 pathway. This study found that high levels of p53 beta, a N-terminally truncated variant, were significantly associated with worse disease-free survival, especially in tumors with wild-type TP53, suggesting that p53 beta may serve as a prognostic marker in breast cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

A Novel Role of SMG1 in Cholesterol Homeostasis That Depends Partially on p53 Alternative Splicing

Muyang Li, Fredrick Philantrope, Alexandra Diot, Jean-Christophe Bourdon, Patricia Thompson

Summary: In this study, we found that inhibition of SMG1 in MCF7 tumor cells induces increased expression of p53 beta and p53 gamma, as well as upregulation of several cholesterol pathway genes. Our study also revealed that silencing SMG1 leads to increased expression of ABCA1, a cholesterol efflux pump, and this may be related to the differential effects of p53 isoforms on cholesterol gene expression.

CANCERS (2022)

Article Cell Biology

Alterations in the p53 isoform ratio govern breast cancer cell fate in response to DNA damage

Luiza Steffens Reinhardt, Xiajie Zhang, Kira Groen, Brianna C. Morten, Geoffry N. De Iuliis, Antony W. Braithwaite, Jean-Christophe Bourdon, Kelly A. Avery-Kiejda

Summary: This study found that the response of breast cancer cells to DNA-damaging therapies in standard care is dependent on the expression of p53 isoforms. A high Delta 40p53:p53 alpha ratio causes cells to respond differently to doxorubicin and cisplatin treatments, increasing resistance to doxorubicin and promoting DNA repair, thereby impairing the cells' normal response.

CELL DEATH & DISEASE (2022)

Meeting Abstract Oncology

Δ133p53a isoform enhances T cell resilience and promotes effective adoptive TCR therapy

K. Legscha, E. Antunes, M. Awwad, G. Ton, G. Borhane, M. Hundemer, J. -C Bourdon, M. Theobald, H. Echchannaoui

ONCOLOGY RESEARCH AND TREATMENT (2021)

Meeting Abstract Oncology

The effect of P53 and its N-terminally truncated isoform, Δ40p53, on breast cancer migration and invasion

Xiajie Zhang, Kira Groen, Brianna C. Morten, Luiza Steffens Reinhardt, Hamish G. Campbell, AntonyW. Braithwaite, Jean-Christophe Bourdon, Kelly A. Avery-Kiejda

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2021)

Correction Biochemistry & Molecular Biology

Ribosomal RNA 2′ O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer (vol 2, zcaa036, 2020)

Virginie Marcel, Janice Kielbassa, Virginie Marchand, Kundhavai S. Natchiar, Hermes Paraqindes, Flora Nguyen Van Long, Lilia Ayadi, Valerie Bourguignon-Igel, Piero Lo Monaco, Deborah Monchiet, Veronique Scott, Laurie Tonon, Susan E. Bray, Alexandra Diot, Lee B. Jordan, Alastair M. Thompson, Jean-Christophe Bourdon, Thierry Dubois, Fabrice Andre, Frederic Catez, Alain Puisieux, Yuri Motorin, Bruno P. Klaholz, Alain Viari, Jean-Jacques Diaz

NAR CANCER (2021)

暂无数据